|
FAM48A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.666000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.708200E-01 |
| Normal-vs-Stage2 |
2.982500E-02 |
| Normal-vs-Stage3 |
8.646000E-02 |
| Normal-vs-Stage4 |
1.969030E-01 |
| Stage1-vs-Stage2 |
9.617400E-03 |
| Stage1-vs-Stage3 |
1.631910E-02 |
| Stage1-vs-Stage4 |
1.250650E-01 |
| Stage2-vs-Stage3 |
4.160800E-01 |
| Stage2-vs-Stage4 |
3.527200E-01 |
| Stage3-vs-Stage4 |
7.861600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.921600E-01 |
| Normal-vs-AfricanAmerican |
6.866200E-01 |
| Normal-vs-Asian |
4.762200E-01 |
| Caucasian-vs-AfricanAmerican |
9.445000E-01 |
| Caucasian-vs-Asian |
1.336760E-01 |
| AfricanAmerican-vs-Asian |
3.891800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.110600E-01 |
| Normal-vs-Female |
3.428000E-01 |
| Male-vs-Female |
3.398800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.886400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.728200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.311540E-02 |
| Normal-vs-Age(81-100Yrs) |
1.672280E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.635500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.764180E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.799850E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.899500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.950300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.035000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.088000E-02 |
| Classical-VS-Follicular |
1.360420E-01 |
| Classical-VS-Other |
1.864650E-01 |
| Classical-VS-Normal |
9.736000E-01 |
| Tall-VS-Follicular |
5.433000E-01 |
| Tall-VS-Other |
1.062550E-01 |
| Tall-VS-Normal |
6.717900E-02 |
| Follicular-VS-Other |
1.658610E-01 |
| Follicular-VS-Normal |
2.191800E-01 |
| Other-VS-Normal |
2.058600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.536820E-01 |
| Normal-vs-N1 |
5.733800E-01 |
| N0-vs-N1 |
7.502100E-02 |
|
|
